Transcutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial.

People with fibromyalgia often find that pain and fatigue worsen during physical activity, which can make everyday movement discouraging. This trial asked whether transcutaneous electrical nerve stimulation, or TENS, used during activity could ease that movement-related pain and fatigue more than a placebo device or no device at all. Women with fibromyalgia were randomly assigned to active TENS, placebo TENS, or no TENS, and used their device at home during activity for two hours a day over four weeks. After four weeks, those using active TENS reported a greater reduction in pain and fatigue experienced during movement compared with both other groups, and more of them reported feeling improved overall.

The result is interesting because it targets a symptom, pain during activity, that is central to how fibromyalgia limits daily life. The main limitation is that this was a single trial over a short period, using self-reported outcomes, so it does not tell us how TENS performs over longer use or in everyday, less structured settings.

If you live with fibromyalgia, you probably know that moving around can make pain and tiredness worse, not better. Researchers wanted to see whether a small device that sends mild electrical pulses through the skin, called TENS, could help when used during activity rather than at rest. Women with fibromyalgia were split into three groups: one used a real TENS device, one used a device that looked identical but delivered no real stimulation, and one used no device.

Everyone wore or used their assigned device for two hours a day during activity for four weeks. The group using the real device reported less pain and fatigue during movement, and more people in that group said they felt improved, compared with the placebo and no-device groups. This is a single trial lasting four weeks, and the results depend on how people rated their own symptoms, so it does not tell us whether the benefit lasts longer or how well it would work as part of daily life outside a study setting.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This randomized, controlled trial compared active TENS, placebo TENS, and no TENS in women with fibromyalgia (n=103, n=99, n=99 respectively) on a stable medication regimen, applied to lumbar and cervicothoracic regions during two hours of daily activity for four weeks. The primary outcome, movement-evoked pain rated on an 11-point scale, showed a statistically significant between-group difference favoring active TENS over placebo (mean difference -1.0, 95% CI -1.8 to -0.2, P=0.008) and over no TENS (mean difference -1.8, 95% CI -2.6 to -1.0, P<0.0001). Movement-evoked fatigue followed a similar pattern, with active TENS outperforming placebo (mean difference -1.4, 95% CI -2.4 to -0.4, P=0.001) and no TENS (mean difference -1.9, 95% CI -2.9 to -0.9, P<0.0001).

Global impression of change ratings also favored active TENS (70% reporting improvement versus 31% placebo and 9% no TENS, P<0.0001), though this is a secondary, self-reported outcome. Minor adverse events occurred in under 5% of participants, with no serious TENS-related events reported. Strengths include the placebo-controlled design and inclusion of a true no-treatment arm, but the four-week duration limits inference about longer-term effects, and outcomes rely entirely on patient self-report, leaving real-world effectiveness and durability unestablished.